A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Enzalutamide Impurity 75 - Request Quote

Picture of Enzalutamide Impurity 75

Enzalutamide Impurity 75

SZ CAT No:SZ-E015103
CAS No
NA
Mol.F.
C14H16FNO4
Mol.Wt.
281.3
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Enzalutamide Impurity 75 is chemically 4-((1-(allyloxy)-2-methyl-1-oxopropan-2-yl)amino)-2-fluorobenzoic acid. Enzalutamide Impurity 75 is supplied with detailed characterization data compliant with regulatory guideline. Enzalutamide Impurity 75 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Enzalutamide.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Enzalutamide Impurity 75

Purchase Enzalutamide Impurity 75

Enzalutamide Impurity 75 suppliers

Enzalutamide Impurity 75 manufacturers

Enzalutamide Impurity 75 price

Order Enzalutamide Impurity 75

Enquire Enzalutamide Impurity 75

Enzalutamide Impurity 75 cost

Enzalutamide Impurity 75 Supplier

Enzalutamide Impurity 75 Distributor

Enzalutamide Impurity 75 for Method Validation

Enzalutamide Reference Standard

Enzalutamide Impurity 75 for ANDA Filing

Enzalutamide Impurity 75 for Forced Degradation Studies

Enzalutamide Impurity 75 Identification Standards

Enzalutamide Impurity 75 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,